Article
TEG001 Insert Integrity from Vector Producer Cells until Medicinal Product.
Molecular therapy : the journal of the American Society of Gene Therapy - 5 Feb 2020
Straetemans Trudy, Janssen Anke, Jansen Koen, Doorn Ruud, Aarts Tineke, van Muyden Anna D D, Simonis Marieke, Bergboer Judith, de Witte Moniek, Sebestyen Zsolt, Kuball Jurgen
Abstract excerpt
Despite extensive usage of gene therapy medicinal products (GTMPs) in clinical studies and recent approval of chimeric antigen receptor (CAR) T cell therapy, little information has been made available on the precise molecular characterization and possible variations in terms of insert integrity and vector copy numbers of different GTMPs during the complete production chain. Within this context, we characterize...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.